|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500103260 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-27 12:09:06 |
|
注册时间: Date of Registration: |
2025-05-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
以e-health慢病管理模型为基础的儿童哮喘全程管理模式及新技术的研究和应用 |
|
Public title: |
Research and Application of an Integrated Management Model and Novel Technologies for Childhood Asthma Based on the E-Health Chronic Disease Management Framework |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
以e-health慢病管理模型为基础的儿童哮喘全程管理模式及新技术的研究和应用 |
|
Scientific title: |
Research and Application of an Integrated Management Model and Novel Technologies for Childhood Asthma Based on the E-Health Chronic Disease Management Framework |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
周佳丽 |
研究负责人: |
周佳丽 |
|
Applicant: |
Jiali Zhou |
Study leader: |
Jiali Zhou |
|
申请注册联系人电话: Applicant telephone: |
+86 133 0162 6175 |
研究负责人电话:
Study leader's |
+86 133 0162 6175 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
carrycarie000@126.com |
研究负责人电子邮件: Study leader's E-mail: |
carrycarie000@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
贵州省贵阳市观山湖区石标路246号 |
研究负责人通讯地址: |
贵州省贵阳市观山湖区石标路246号 |
|
Applicant address: |
No. 246, Shibiao Road, Guanshanhu District, Guiyang City, Guizhou Province, China |
Study leader's address: |
No. 246, Shibiao Road, Guanshanhu District, Guiyang City, Guizhou Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海交通大学医学院附属上海儿童医学中心贵州医院 |
||
|
Applicant's institution: |
Guizhou Branch of Shanghai Children's Medical Center Shanghai Jiaotong University School of Medicine |
||
|
研究负责人所在单位: |
上海交通大学医学院附属上海儿童医学中心贵州医院 |
||
|
Affiliation of the Leader: |
Guizhou Branch of Shanghai Children's Medical Center Shanghai Jiaotong University School of Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦审(科研)2025-041号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海交通大学医学院附属上海儿童医学中心贵州医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of shanghai Children’s Medical Center Guizhou Hospital,Shanghai Jiao Tong University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-04-09 00:00:00 | ||
|
伦理委员会联系人: |
李合 |
||
|
Contact Name of the ethic committee: |
He Li |
||
|
伦理委员会联系地址: |
贵州省贵阳市观山湖区石标路246号 |
||
|
Contact Address of the ethic committee: |
No. 246, Shibiao Road, Guanshanhu District, Guiyang City, Guizhou Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 851 8895 5075 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海交通大学医学院附属上海儿童医学中心贵州医院护理部 |
||||||||||||||||||||||
|
Primary sponsor: |
Nursing Department, Guizhou Branch of Shanghai Children's Medical Center Shanghai Jiaotong University School of Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
贵州省贵阳市观山湖区石标路246号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 246, Shibiao Road, Guanshanhu District, Guiyang City, Guizhou Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
2025年贵州省科技成果转化及产业化计划项目(临床专项) |
||||||||||||||||||||||
|
Source(s) of funding: |
Clinical Research Special Project under Guizhou Province's 2025 Science and Technology Achievement Transformation and Industrialization Program |
||||||||||||||||||||||
|
研究疾病: |
儿童哮喘 |
||||||||||||||||||||||
|
Target disease: |
Childhood Asthma |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
1. 主要目的:提高患儿哮喘管理水平基础上提高哮喘控制水平,从而改善哮喘患儿的结局; 2. 次要目的:构建融合e-health慢病管理模型的多团队合作的儿童哮喘管理门诊;形成规范的哮喘分级诊疗方案。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Main Objective Enhance the management efficacy of pediatric asthma and improve asthma control, thereby optimizing clinical outcomes in children with asthma. 2. Secondary Objectives Develop a multidisciplinary collaborative pediatric asthma management clinic integrating the e-health chronic disease management model. Establish a standardized asthma grading diagnosis and treatment protocol. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.符合2024版GINA指南中哮喘的诊断标准,诊断为哮喘; 2.年龄在4~18岁的患儿; 3.同意参加此次研究的哮喘患儿; 4.至少有一位父母/主要照顾者/患儿拥有智能手机。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Patients who meet the diagnostic criteria for asthma as outlined in the 2024 Global Initiative for Asthma (GINA) guidelines and have been diagnosed with asthma. 2.Children aged between 4 and 18 years. 3.Children with asthma and their parents or legal guardians who agree to participate in this study. 4.Availability of a smartphone among at least one parent, primary caregiver, or the child themselves. |
||||||||||||||||||||||
|
排除标准: |
1.有其他急、慢性合并症的患儿; 2.家属不会使用APP软件的患儿。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Children with other acute or chronic comorbid conditions. 2.Children whose family members are unable to use mobile application software. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-27 00:00:00至 To 2026-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-05-27 00:00:00 至 To 2026-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
为防止沾染效应,将其按照时间顺序分为对照组和干预组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
To prevent contamination effects, they were divided into a control group and an intervention group in chronological order. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集使用上海儿童医学中心贵州医院呼吸内科记录表;数据管理使用上海儿童医学中心贵州医院呼吸内科数据库进行管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection was performed using the respiratory department record form from the Guizhou Hospital of Shanghai Children’s Medical Center. Data management was conducted using the respiratory database of the Guizhou Hospital of Shanghai Children’s Medical Center. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |